With the current mania in the market today, as long as PFE meets analysts' expectations, it will at least hold its value. With three blockbuster new products in the pipeline in the next 18 months, PFE will clearly outperform most major drug companies. As a physician, I use PFE products daily. COMPETITIVE ADVANTAGE is the key here!
Aricept, Cardura, Diflucan, Zoloft, Procardia, Glucotrol, Lipitor, Zithromax, Norvasc, Unasyn, Zyrtec, and coming soon...Viagra (pill for impotence) and two others. This formulary is incredible! It's hard NOT to own a piece of this company!